Press Release
« Back
Manhattan Pharmaceuticals to Present At Acumen/BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference
May 09, 2007
NEW YORK, May 9, 2007 - Manhattan Pharmaceuticals, Inc. (AMEX:MHA - News) today announced that Douglas Abel, president and chief executive officer, will present at the Acumen/BioFin Rodman and Renshaw 4th Annual Global Healthcare Conference on Monday, May 14 at 5:50am EDT (11:50am local time). The conference is being held May 14-15, 2007 at the Le Meriden Beach Plaza Resort in Monte Carlo, Monaco.
To access the live audio webcast for this presentation please go to http://www.manhattanpharma.com approximately 15 minutes prior to the presentation in order to register and download any necessary software.
About Manhattan Pharmaceuticals, Inc.
Manhattan Pharmaceuticals, Inc., (AMEX:MHA - News) is a pharmaceutical company developing novel, high-value drug candidates primarily in the areas of endocrine/metabolic disease and dermatologic/immunologic disorders. With a pipeline consisting of five clinical-stage product candidates, Manhattan Pharmaceuticals is developing potential therapeutics for large, underserved patient populations seeking superior treatments for conditions including common obesity, morbid obesity, psoriasis, and atopic dermatitis (eczema).
